Vay, Manuela Dr. sc. hum.Universität HeidelbergHeidelberg
Refine publication list
Year of publication
Type of Publication
Language
Co-author (Univ. of Heidelberg)
Co-author (external)
Publications in heiBIB 
- Vay, Manuela: Oral yohimbine as a new probe drug to predict CYP2D6 activity : results of a fixed-sequence phase I trial / Manuela Vay, Marleen Julia Meyer, Antje Blank, Gisela Skopp, Peter Rose, Mladen Vassilev Tzvetkov, G… , 15 February 2020. - 13 S.
In: Clinical pharmacokinetics, ISSN 1179-1926. 59(2020), 7, Seite 927-939
DOI: 10.1007/s40262-020-00862-6
- Vay, Manuela: Analytische und klinische Untersuchungen zur Etablierung von Yohimbin als Marker zur Phänotypisierung von CYP2D6 / vorgelegt von Manuela Vay ; Doktorvater: apl. Prof. Dr. med. Gerd Mikus. -
Heidelberg, 2019. - XI, 120 Blätter : Illustrationen, Diagramme
- Vay, Manuela: Quantification of microdosed oral yohimbine and its major metabolite in human plasma in the picogram range / Manuela Vay, Max Sauter, Gerd Mikus & Jürgen Burhenne. - Zweitveröffentlichung. -
London: Future Science, 2019. - 1 Online-Ressource (12 Seiten)
DOI: 10.11588/heidok.00028431
- Vay, Manuela: Simultaneous quantification of the CYP2D6 substrate yohimbine, its metabolite 11-OH-yohimbine, and the CYP2D6 inhibitor paroxetine in human plasma / Manuela Vay, Gisela Skopp, Gerd Mikus and Jürgen Burhenne, 4 November 2019. - 8 S.
In: Analytical methods, ISSN 1759-9679. 11(2019), 47, Seite 5976-5983
DOI: 10.1039/C9AY01715A
- Vay, Manuela: Isotopically labelled paroxetine standard allows for definite structure elucidation of the paroxetine tandem mass spectrum / Manuela Vay, Marius Majewsky, Gerd Mikus, 2018 Aug 15. - 2 S.
In: Rapid communications in mass spectrometry, ISSN 1097-0231. 32(2018), 15, Seite 1311-1312
DOI: 10.1002/rcm.8178
- Vay, Manuela: No alteration of voriconazole concentration by plasmapheresis in a critically ill patient : letter to the editor / Manuela Vay, Kathrin I. Foerster, Mazyar Mahmoudi, Jessica Seeßle, Gerd Mikus, 2019. - 2 S.
In: European journal of clinical pharmacology, ISSN 1432-1041. 75(2019), 2, Seite 287-288
DOI: 10.1007/s00228-018-2582-6
